Key facts
- This page summarizes Jodi Devlin's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 31 Aug 2023, 21:04.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of August 28, 2023, and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the vesting commencement date.